NVAX is a risky biotech that regularly takes heavy blows and could fall sharply again, so it should not be a large position; it is behaving well at the moment, and the speaker holds a small long position and hopes to add.
Jump to any passage
Um, and I bought some NVAX today. This is, you know, a fairly risky biotech stock. It surfaced two weeks ago because of that Russian news about Ebola or whatever was going on there.
I have no idea. Um, what was it ? The plague. Oh, the plague. That's right. Pneumonic plague . It's back, Brian. It is back. So, here is the weekly chart of this stock. And you know, it's a risky little biotech company.
It regularly takes heavy blows. So you shouldn't invest too much in it, because this is what most people don't pay attention to when looking at the stock, and it could easily go the same way again tomorrow.
But at the moment, it is behaving well. So I have a small position in this stock, and my stop loss will probably be below the lowest price of the day . Hopefully, I can increase that.